Effects of physical exercise on cardiovascular sequels caused by SARS-CoV-2: a case study
DOI:
https://doi.org/10.17058/rips.v8i1.18603Keywords:
Covid-19, Case report, Rehabilitation, Physical exercisesAbstract
Introduction: the Covid-19 pandemic has had a significant impact on global health, resulting in many patients experiencing post-infection sequelae such as cardiovascular issues and hemodynamic alterations. These conditions are commonly reported in cases known as "Long Covid". The use of physical exercise (PE) as part of rehabilitation has shown promise in alleviating persistent symptoms following infection. Objective: To evaluate the therapeutic role of exercise on hypertension and physical fitness as a post-infection sequelae of SARS-CoV-2. Method: this is a case study conducted with a 52-year-old patient referred by the Health Department to continue treatment with PE. The patient underwent clinical anamnesis, reporting post-SARS-CoV-2 sequelae including chronic fatigue and hypertension, and a physical evaluation including anthropometric measurements (body mass, height, waist circumference-WC), motor tests (abdominals, 6-minute walk test), and vital capacity (spirometry). Subsequently, the patient was individually monitored for 90 days in a PE program following the scientific evidence of the American College Sports Medicine, conducted twice a week, with a duration of 60 minutes per session. The program included aerobic activities and resistance training as the main part of the treatment. Results: following program completion, the patient reported improved disposition (increased endurance), and increases were observed in the distance covered in the 6-minute walk test (5%) and in vital capacity (3%). Additionally, there was a reduction in body mass (3%), WC (3%), and normalization of blood pressure. Conclusion: these results indicate that the exercise program, conducted twice a week for 90 days, demonstrated effectiveness both qualitatively (patient perception) and quantitatively (improvement in performance and reduction in blood pressure measures) in an individual with cardiovascular sequelae post-Covid-19.
Downloads
References
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020 Jul 1; 75(7):1730–41. doi: https://doi.org/10.1111/all.14238
Zhou, Y., Chi, J., Lv, W., & Wang, Y. Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid‐19). Diabetes Metab Res Rev 2021; 37(2):e3377. doi: https://doi.org/10.1002/dmrr.3377 PMID: 32588943
Sallis R, Young DR, Tartof SY, Sallis JF, Sall J, Li Q, et al. Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: A study in 48 440 adult patients. Br J Sports Med 2021 Oct 1; 55(19):1099–105. doi: https://doi.org/10.1136/bjsports-2021-104080 PMID: 33849909
Saes MO. Covid longa. Vittalle. 2021; 33(3):7–8. doi: https://doi.org/10.14295/vittalle.v33i3.13833
Schwendinger F, Knaier R, Radtke T, Schmidt-Trucksäss A. Low Cardiorespiratory Fitness Post-COVID-19: A Narrative Review. Sports Med 2022 Sep 17; 53:51-74. doi: https://doi.org/10.1007/s40279-022-01751-7 PMID: 36115933
Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It? Lung 2021 Apr 1; 199(2):113–9. doi: https://doi.org/10.1007/s00408-021-00423-z PMID: 33569660
Queiroga MR, Ferreira SA, Vaz EDS, Souza SCS, de Oliveira LEC, Stavinski NG de L, et al. Clínica e Academia Escola de Educação Física: prescrição de exercícios físicos baseados em evidências científicas. Extensio 2019 Aug 28; 16(33):111–22. doi: https://doi.org/10.5007/1807-0221.2019v16n33p111
American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription. 10th ed. Riebe D, Ehrman J k., Liguori G, Magal M, editors. Wolters Kluwer Health; 2018.
American Thoracic Society. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med 2002; 166:111–7. doi: 10.1164/ajrccm.166.1.at1102
Pucci F, Annoni F, dos Santos RAS, Taccone FS, Rooman M. Quantifying renin-angiotensin-system alterations in covid-19. Cells. 2021 Oct 1; 10(10):2755 doi: https://doi.org/10.3390/cells10102755 PMID: 34685735
Tadic M, Saeed S, Grassi G, Taddei S, Mancia G, Cuspidi C. Hypertension and COVID-19: Ongoing Controversies. Front Cardiovasc Med 2021 Feb 17; 8. doi: https://doi.org/10.3389/fcvm.2021.639222 PMID: 33681308
Akpek M. Does COVID-19 Cause Hypertension? Angiology 2022; 73(7):682-687. doi: https://doi.org/10.1177/00033197211053903
Chen G, Li X, Gong Z, Xia H, Wang Y, Wang X, et al. Hypertension as a sequela in patients of SARS-CoV-2 infection. PLoS One 2021 Apr 1; 16(4): e0250815. doi: https://doi.org/10.1371/journal.pone.0250815 PMID: 33909683
Dalan R, Bornstein SR, El-Armouche A, Rodionov RN, Markov A, Wielockx B, et al. The ACE-2 in COVID-19: Foe or Friend? Horm Metab Res 2020 May 1; 52(5):257–63. doi: https://doi.org/10.1055/a-1155-0501 PMID: 32340044
Klöting N, Ristow M, Blüher M. Effects of Exercise on ACE2. Obesity 2020; 28:2266–2267. doi: https://doi.org/10.1002/oby.23041
Petto J, Santos PHS, dos Santos LFS, Sena DSS, Sacramento MS. Interaction between sars-cov-2 and the renin angiotensin system. Rev Pesq Fisio 2021; 11(1): 198–210. doi: https://doi.org/10.17267/2238-2704RPF.V11I1.3412
Downloads
Published
How to Cite
Issue
Section
License
A submissão de originais para este periódico implica na transferência, pelos autores, dos direitos de publicação impressa e digital. Os direitos autorais para os artigos publicados são do autor, com direitos do periódico sobre a primeira publicação. Os autores somente poderão utilizar os mesmos resultados em outras publicações indicando claramente este periódico como o meio da publicação original. Em virtude de sermos um periódico de acesso aberto, permite-se o uso gratuito dos artigos em aplicações educacionais e científicas desde que citada a fonte conforme a licença CC-BY da Creative Commons.